Chemical formula: C₁₀H₁₂FeN₂NaO₈ Molecular mass: 367.047 g/mol
Administration of drugs during the first trimester of pregnancy requires careful assessment of potential risks versus benefits to be gained. No adverse events associated with sodium feredetate administration during pregnancy have been reported.
No adverse events associated with sodium feredetate administration during lactation have been reported.
None known.
Adverse reactions reported as possibly associated to sodium feredetate are presented in the following table by MedDRA System Organ Class (SOC), Preferred Term and frequency. The following frequency categories are used:
Very common (>1/10), Common (>1/100, <1/10), Uncommon (>1/1,000, <1/100), Rare (>1/10,000, <1/1,000), Very rare (<1/10,000)
Post-marketing adverse reactions are reported voluntarily from a population with an unknown rate of exposure. Therefore it is not possible to estimate the true incidence of adverse reactions and the frequency is “unknown”.
Tabulated summary of adverse reactions:
| SYSTEM ORGAN CLASS (SOC) | FREQUENCY | ADVERSE REACTION |
|---|---|---|
| Immune system disorders | Unknown | Hypersensitivity |
| Gastrointestinal disorders | Unknown | Nausea, mild diarrhoea |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
